课题基金 / 基金详情

Assessment oF FluoxetINe In sTroke recoverY (AFFINITY)

Assessment oF FluoxetINe In sTroke recoverY (AFFINITY)
氟西汀在中风恢复中的评估(亲和力)
批准号:
nhmrc : GNT1059094
负责人:
A/Pr Christopher Etherton-Beer
金额:
$221.22万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 --

项目摘要

项目成果

A/Pr Christopher Etherton-Beer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Stroke is one of the top three causes of disability. Treatments that improve recovery after stroke are lacking. We reviewed the world literature and found a number of very small studies which, together, suggest that the antidepressant drug, fluoxetine, may improve the recovery in stroke patients. AFFINITY is a large trial in 1600 Australians and New Zealanders with stroke which aims to find out whether taking fluoxetine for 6 months after a stroke improves recovery compared to a placebo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study.
  • 批准号:
    nhmrc : GNT1139616
  • 项目类别:
    Boosting Dementia Research Initiative
  • 资助金额:
    $58.68万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
BAN-Dep: A trial to decrease the prevalence of depression in Australian Nursing Homes
  • 批准号:
    nhmrc : 1150529
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $58.44万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
BAN-Dep: A trial to decrease the prevalence of depression in Australian Nursing Homes
  • 批准号:
    nhmrc : GNT1150529
  • 项目类别:
    Targeted Calls for Research
  • 资助金额:
    $86.43万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study.
  • 批准号:
    nhmrc : 1139616
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $39.68万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
海外基金